Table 1:
SNP | Chromosome | Gene | Effect allele | Base Pairs* | EAF cases (%) | EAF controls (%) | Allelic OR | 95%-CI | P-value** |
---|---|---|---|---|---|---|---|---|---|
rs11125529 | 2 | ACYP2 | A | 66.9 | 12.7 | 13.3 | 0.95 | 0.82–1.10 | 0.49 |
rs10936599 | 3 | TERC | C | 117.3 | 24.4 | 22.2 | 1.14 | 1.01–1.28 | 0.02 |
rs7675998 | 4 | NAF1 | G | 89.7 | 21.7 | 21.7 | 1.00 | 0.89–1.13 | 0.94 |
rs2736100 | 5 | TERT | C | 94.2 | 52.3 | 49.0 | 1.13 | 1.03–1.25 | 0.01 |
rs9420907 | 10 | OBFC1 | C | 82.8 | 16.7 | 14.1 | 1.22 | 1.07–1.39 | 0.003*** |
rs3027234 | 17 | CTC1 | C | 25.2 | 21.7 | 22.3 | 0.97 | 0.86–1.08 | 0.55 |
rs8105767 | 19 | ZNF208 | G | 57.6 | 30.4 | 28.7 | 1.08 | 0.97–1.20 | 0.15 |
rs755017 | 20 | RTEL1 | G | 74.1 | 13.5 | 12.1 | 1.15 | 1.00–1.33 | 0.05 |
Number of base pairs the affected allele increases the genotypically-estimated leukocyte telomere length (LTL)[13, 32]
p-value for risk for meningioma under an additive frequentist model
Significant after correction for multiple testing (eight degrees of freedom).
Abbreviations: EAF: estimated allele frequency; bp: base pairs, OR: odds ratio, LTL: Leukocyte telomere length.